• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MILTENYI BIOTEC GMBH CLINIMACS PLUS INSTRUMENTS; MAGNETIC CELL SELECTION SYSTEM FOR CD 34+ CELLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MILTENYI BIOTEC GMBH CLINIMACS PLUS INSTRUMENTS; MAGNETIC CELL SELECTION SYSTEM FOR CD 34+ CELLS Back to Search Results
Catalog Number 151-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Bacterial Infection (1735); Death (1802); Dyspnea (1816); Foreign Body Reaction (1868); Renal Failure (2041)
Event Date 06/17/2019
Event Type  Death  
Event Description
Pt is a (b)(6) y/o male with history of recurrent stage iv peripheral t-cell lymphoma.He received a tcr-alpha / beta and cd19 depleted haploidentical stem cell transplant on (b)(6) 2018.Briefly, he has been admitted five times since his bone marrow transplant for a number of cardiac issues, graft-versus- host disease, multiple infections and renal failure.Most recently this pt was admitted on (b)(6) 2019 for worsening dyspnea on exertion and found to be bacteremic.The pt was intubated on (b)(6) 2019 due to persistent hypoxia on cpap.The etiology of this was felt to be multifactorial, and likely largely related to previously known decompensated heart failure.Repeat echocardiograms during this hospitalization did not reveal significant changes in ejection fraction.The pt received continuous renal replacement therapy starting (b)(6).The pt's respiratory status had improved enough to be extubated on friday evening, (b)(6) 2019.He developed worsening abdominal pain on (b)(6), requiring increased pressor support and was thus sent for stat ct angio chest / abdominal / pelvis that suggested extensive intestinal ischemia, thought to be more due to hypoperfusion rather than distal emboli.Wbc count rose and thus infection was suspected.Due to poor prognosis, pt was transitioned to comfort measures and passed on (b)(6) 2019.Autopsy was discussed and not desired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINIMACS PLUS INSTRUMENTS
Type of Device
MAGNETIC CELL SELECTION SYSTEM FOR CD 34+ CELLS
Manufacturer (Section D)
MILTENYI BIOTEC GMBH
MDR Report Key8811392
MDR Text Key151857466
Report NumberMW5088260
Device Sequence Number1
Product Code OVG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 07/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number151-01
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age57 YR
Patient Weight74
-
-